SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-15-000050
Filing Date
2015-06-16
Accepted
2015-06-16 12:36:45
Documents
1
Period of Report
2015-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4048
  Complete submission text file 0001250853-15-000050.txt   5695
Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 15933775

Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)